The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts).
 
Bernard A. Fox
Employment - UbiVac; UbiVac (I)
Leadership - UbiVac
Stock and Other Ownership Interests - UbiVac
Honoraria - Janssen Biotech; Nodality
Consulting or Advisory Role - Dendreon; Janssen Biotech
Research Funding - Aduro Biotech; Bristol-Myers Squibb; DEfiniens; Janssen Biotech; MedImmune (Inst); Perkin Elmer; Ventana Medical Systems; Viralytics
Patents, Royalties, Other Intellectual Property - Patent around the DPV-001 cancer vaccine. This patent is owned by the Providence Health System and licensed to UbiVac
 
Brian C. Boulmay
No Relationships to Disclose
 
Rui Li
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Kyle T Happel
No Relationships to Disclose
 
Christopher Paustian
Employment - UbiVac
Research Funding - UbiVac
Patents, Royalties, Other Intellectual Property - Earle A. Chiles Research Institute
 
Tarsem Lal Moudgil
Patents, Royalties, Other Intellectual Property - Earle A. Chiles Research Institute
 
Sachin Puri
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Christopher Dubay
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Yoshinobu Koguchi
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Agonox
 
Adi Mehta
No Relationships to Disclose
 
Fridtjof Lund-Johansen
No Relationships to Disclose
 
Brenda K Fisher
Travel, Accommodations, Expenses - IRX Therapeutics
 
William L Redmond
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics; IRX Therapeutics; MedImmune (Inst); Merck; Nektar; Tesaro
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Tesaro
 
Carlo Bruno Bifulco
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Augusto Ochoa
No Relationships to Disclose
 
Hong-Ming Hu
Employment - UbiVac
Leadership - UbiVac
Consulting or Advisory Role - Jiangsu Hengrui Medicine
Research Funding - Jiangsu Hengrui Medicine; MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Earle A. Chiles Research Institute
 
Traci Hilton
Employment - UbiVac
 
Walter John Urba
Leadership - Leidos Biomedical Research
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb/Medarex; Celldex; eTheRNA; GreenPeptide; MedImmune; MedImmune (Inst); OncoSec
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - AgonOx; Bristol-Myers Squibb; eTheRNA; Leidos Biomedical Research; MedImmune
 
Rachel E. Sanborn
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; ARIAD; Genentech/Roche; Peregrine Pharmaceuticals; Seagen
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - Five Prime Therapeutics